| ATRICURE INC. DL-,001 |
| USA |
| Gesundheit |
| US04963C2098 / A0ES9W |
| A5I (Frankfurt) / ATRC (NASDAQ) |
| FRA:A5I, ETR:A5I, A5I:GR, NASDAQ:ATRC |
| - |
| https://www.atricure.com/ |
|
AtriCure, Inc. is a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. The company develops and provides advanced medical technologies used by electroph..
>Volltext.. |
| 1253.72 Mio. EUR |
| 1176.14 Mio. EUR |
| 456.06 Mio. EUR |
| 14.58 Mio. EUR |
| -9.77 Mio. EUR |
| -0.21 EUR |
| 65.27 Mio. EUR |
| 142.85 Mio. EUR |
| 48.92 Mio. EUR |
| 2.05 |
| 14.88% |
| 74.39% |
| - |
| - |
| - |
| - |
| ATRICURE |
| 06.05.26 |
|
||||
|
||||
|
||||
|
||||
|